Literature DB >> 8388478

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

M H Schiffman1, H M Bauer, R N Hoover, A G Glass, D M Cadell, B B Rush, D R Scott, M E Sherman, R J Kurman, S Wacholder.   

Abstract

BACKGROUND: Experimental studies have provided strong evidence that human papillomavirus (HPV) is the long-sought venereal cause of cervical neoplasia, but the epidemiologic evidence has been inconsistent.
PURPOSE: Given improvements in HPV testing that have revealed a strong link between sexual activity history and cervical HPV infection, we conducted a large case-control study of HPV and cervical intraepithelial neoplasia (CIN) to evaluate whether sexual behavior and the other established risk factors for CIN influence risk primarily via HPV infection.
METHODS: We studied 500 women with CIN and 500 control subjects receiving cytologic screening at Kaiser Permanente, a large prepaid health plan, in Portland, Ore. The established epidemiologic risk factors for CIN were assessed by telephone interview. We performed HPV testing of cervicovaginal lavage specimens by gene amplification using polymerase chain reaction with a consensus primer to target the L1 gene region of HPV. Unconditional logistic regression analysis was used to estimate relative risk of CIN and to adjust the epidemiologic associations for HPV test results to demonstrate whether the associations were mediated by HPV.
RESULTS: The case subjects demonstrated the typical epidemiologic profile of CIN: They had more sex partners, more cigarette smoking, earlier ages at first sexual intercourse, and lower socioeconomic status. Statistical adjustment for HPV infection substantially reduced the size of each of these case-control differences. Seventy-six percent of cases could be attributed to HPV infection; the results of cytologic review suggested that the true percentage was even higher. Once HPV infection was taken into account, an association of parity with risk of CIN was observed in both HPV-negative and HPV-positive women.
CONCLUSION: The data show that the great majority of all grades of CIN can be attributed to HPV infection, particularly with the cancer-associated types of HPV. IMPLICATIONS: In light of this conclusion, the investigation of the natural history of HPV has preventive as well as etiologic importance.

Entities:  

Keywords:  Americas; Biology; Cancer; Case Control Studies; Cervical Cancer; Developed Countries; Diseases; Epidemiology; Health; Hpv; Neoplasms; North America; Northern America; Oregon; Public Health; Research Methodology; Research Report; Risk Factors; Studies; United States; Viral Diseases

Mesh:

Substances:

Year:  1993        PMID: 8388478     DOI: 10.1093/jnci/85.12.958

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  205 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible.

Authors:  Philip E Castle; Attila T Lorincz; Iwona Mielzynska-Lohnas; David R Scott; Andrew G Glass; Mark E Sherman; John E Schussler; Mark Schiffman
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens.

Authors:  J U Cope; A Hildesheim; M H Schiffman; M M Manos; A T Lörincz; R D Burk; A G Glass; C Greer; J Buckland; K Helgesen; D R Scott; M E Sherman; R J Kurman; K L Liaw
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

4.  The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies.

Authors:  Julia C Gage; Kayode O Ajenifuja; Nicolas A Wentzensen; Akinfolarin C Adepiti; Claire Eklund; Mary Reilly; Martha Hutchinson; Sholom Wacholder; Joe Harford; Amr S Soliman; Robert D Burk; Mark Schiffman
Journal:  Int J Cancer       Date:  2011-08-05       Impact factor: 7.396

5.  Detection of human papillomavirus DNA in pterygia from different geographical regions.

Authors:  F Piras; P S Moore; J Ugalde; M T Perra; A Scarpa; P Sirigu
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

6.  Fourier transform infrared (FTIR) spectral mapping of the cervical transformation zone, and dysplastic squamous epithelium.

Authors:  B R Wood; L Chiriboga; H Yee; M A Quinn; D McNaughton; M Diem
Journal:  Gynecol Oncol       Date:  2004-04       Impact factor: 5.482

7.  Methods of model calibration: observations from a mathematical model of cervical cancer.

Authors:  Douglas C A Taylor; Vivek Pawar; Denise Kruzikas; Kristen E Gilmore; Ankur Pandya; Rowan Iskandar; Milton C Weinstein
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

8.  Impact of improved classification on the association of human papillomavirus with cervical precancer.

Authors:  Philip E Castle; Mark Schiffman; Cosette M Wheeler; Nicolas Wentzensen; Patti E Gravitt
Journal:  Am J Epidemiol       Date:  2009-12-10       Impact factor: 4.897

9.  Invited commentary: Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions.

Authors:  Eduardo L Franco; Joseph Tota
Journal:  Am J Epidemiol       Date:  2009-12-10       Impact factor: 4.897

Review 10.  Gynecologic issues in the HIV-infected woman.

Authors:  Helen E Cejtin
Journal:  Infect Dis Clin North Am       Date:  2008-12       Impact factor: 5.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.